RIM
AZN icon

Redpoint Investment Management’s AstraZeneca AZN Stock Holding History

Redpoint Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$216K Sell
1,970
-4,585
-70% -$582K 0.03% 547
2022
Q2 		$866K Hold
6,555
– – 0.1% 240
2022
Q1 		$870K Hold
6,555
– – 0.09% 272
2021
Q4 		$764K Hold
6,555
– – 0.06% 352
2021
Q3 		$787K Buy
+6,555
New +$763K 0.07% 332

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Redpoint Investment Management's AZN Position: Q3 2022 in Review

Redpoint Investment Management reduced its AstraZeneca (AZN) stake by 70% in Q3 2022, selling an estimated $582K and leaving 1,970 shares worth $216K. The position accounts for 0.03% of the portfolio, ranked #547.

Redpoint Investment Management first reported a position in AZN in Q3 2021 and has held it in 5 quarters since. The position peaked at $870K in Q1 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • Redpoint Investment Management held 1,970 shares of AstraZeneca worth $216K as of Q3 2022.
  • Redpoint Investment Management sold 4,585 AstraZeneca shares in Q3 2022, an estimated $582K.
  • AstraZeneca made up 0.03% of Redpoint Investment Management's portfolio in Q3 2022, its #547 holding.
  • Redpoint Investment Management first reported a position in AstraZeneca in Q3 2021 and has held it in 5 quarters since.
  • Redpoint Investment Management's AstraZeneca position peaked at $870K in Q1 2022.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.